City

Dallas (2)

Cartagena (1)

Guangzhou (1)

Condition

Astrocytomas (4)

Oligodendrogliomas (3)

Malignant Gliomas (2)

Brain Tumors (1)

Gliomas (1)

Meningiomas (1)

Neoplasms (1)

Oligoastrocytoma (1)

Overall Status

Completed (2)

Terminated (1)

Unknown status (1)

Sign in for free

Phase

phase 3 (2)

Sponsor

University of Texas Southwestern Medical Center (2)

Colombian Foundation for Epilepsy and Neurological Disease (1)

Sun Yat-sen University (1)

Collaborator

Cancer Prevention Research Institute of Texas (1)

National Cancer Institute (NCI) (1)

National Institutes of Health (NIH) (1)

Intervention

3 tesla scanning (2)

7 tesla scanning (1)

placebo: saline (1)

radiation therapy (1)

temozolomide (1)

tranexamic acid (1)

Study Documents

Intervention Type

device (2)

drug (2)

radiation (1)

Funder Type

Other (4)

Study Type

Interventional (2)

Observational (2)

astrocytomas

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Clinical Development of Cancer-Specific MRS Biomarkers in

Completed

Malignant Gliomas
+2 more

3 Tesla scanning

Dallas, Texas

UT Southwestern Medical Center

Jan 19, 2022

Clinical Development of MR Spectroscopy and Imaging in Brain

Completed

Malignant Gliomas
+2 more

3 Tesla Scanning
7 Tesla Scanning

Dallas, Texas

UT Southwestern Medical Center

Jan 19, 2022

Astrocytomas, Oligodendrogliomas, Oligoastrocytoma Trial in Guangzhou (Radiation therapy, Temozolomide)

Terminated

Astrocytomas
+2 more

Radiation therapy
Temozolomide

Guangzhou, Guangdong, China

Sun Yat-sen University

Aug 4, 2014

Brain Tumors, Tumors, Gliomas Trial in Cartagena (Tranexamic Acid, Placebo: Saline)

Unknown status

Brain Tumors
+4 more

Tranexamic Acid
Placebo: Saline

Cartagena, Bolivar, Colombia

Colombian foundation center for epilepsy and neurological diseas

Jul 31, 2012